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Abstract
Rod-like structures composed of actin and the actin-binding protein cofilin are found in Alzheimer’s disease (AD) patients.
However, the mechanisms underlying formation of these structures and their pathological consequences are still largely
unknown. We found that microRNAs 103 and 107 repress translation of cofilin, and that reduced levels of miR-103 or miR-
107 are associated with elevated cofilin protein levels and formation of rod-like structures in a transgenic mouse model of
AD. These results suggest that microRNAs may play an important role in cytoskeletal pathology in AD.
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Introduction
In addition to amyloid plaques and neurofibrillary tangles,
Alzheimer’s disease (AD) brains contain Hirano bodies [1], which
are rod-like structures composed largely of actin and the actin-
binding protein cofilin [2], as well as other aggregates of actin and
cofilin [3]. Cofilin regulates actin turnover [4–6], and abnormal-
ities of cofilin directly affect the structure, dynamics, and functions
of the cytoskeleton [3,7]. In primary neurons, ATP depletion,
excitotoxicity, and amyloid-b peptide treatment induce formation
of cofilin rods [3]. These rods destroy microtubule bundles in
neurites and interfere with neuritic transport and synaptic
structure and activity [7,8]. A recent study suggested that
abnormal cofilin aggregation may initiate tau neuropil threads
[9]. Thus, these cofilin-actin inclusions may play an essential role
in AD pathogenesis. However, the mechanisms underlying cofilin-
actin rod formation are still largely unknown.
MicroRNAs (miRNAs) have recently been implicated in
neurodegenerative diseases [10], including Parkinson’s disease
[11] and AD [12–14]. Mature miRNAs are short (21–22 nt)
noncoding RNAs that bind the 39 untranslated region (UTR) of
mRNAs and mainly repress translation. A large number of
miRNAs are expressed in brain and potentially regulate expression
of many genes. Of note, miR-107 is decreased in postmortem AD
human brain, and has been associated with an increase in
expression of b-site amyloid precursor protein cleavage enzyme 1
(BACE1) [12], thus linking miRNAs with an important suspected
pathway in AD pathogenesis.
We show for the first time that (1) miR-103 and miR-107 repress
cofilin translation, (2) reduced levels of miR-103 or miR-107 increase
cofilin protein levels, and (3) increased levels of active cofilin protein
leads to the formation of cofilin rods. Importantly, we show also that
miR-103 and miR-107 levels are decreased and cofilin protein levels
increased in brains of a transgenic mouse model of AD.
Results
Cofilin protein level is significantly increased in APP
transgenic mouse brains and neurons
To determine whether cofilin expression level contributes to
formation of rod-like structures, we examined cofilin levels in
brains and primary neurons from Tg19959 mice, which
overexpress human APP carrying the KM670/671NL and
V717F familial AD mutations. Tg19959 mice develop brain
amyloid deposition and cognitive deficits at the age of 4 months.
Protein extracted from 4-month-old Tg19959 mouse brains was
analyzed by western blot. Brain levels of cofilin were increased 1.3-
fold in Tg19959 mice compared to wildtype littermates (Fig. 1a).
In cultured primary neurons (DIV 16), cofilin levels were increased
2-fold in neurons from Tg19959 embryos compared to those from
wild-type littermates (Fig. 1b).
Cofilin rod-like structures are detected in Tg19959
primary neurons and brain
Cofilin and actin form rod-like structures in postmortem AD
brains [1,3]. When cells were permeabilized with ice-cold
methanol (which is ideal for visualizing cofilin rods, [3,15]), we
also found rod-like structures immunoreactive for cofilin in
Tg19959 primary neurons, but only rarely in wildtype littermate
neurons (Fig. 2a). The fraction of neurons containing cofilin rods
was 3-fold higher in Tg19959 neurons compared to wild-type
neurons (23.963.1% vs 7.362.1%, Fig. 2b).
It has been previously described that cofilin-actin rods are not
detected by rhodamine-phalloidin, even though rhodamine-
phalloidin normally binds filamentous actin. It has been suggested
that the actin cytoskeleton in this structure is saturated with cofilin
protein, which blocks binding of rhodamine-phalloidin [3,16]. As
expected, when we permeabilized cells with Triton X-100 (ideal
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rhodamine-phalloidin (Fig. 2c). However, the cofilin rods in
Tg19959 neurons do contain actin, as shown by staining with a
total actin antibody (Fig. S1).
In addition to primary neurons, we detected abnormal
aggregates strongly immunoreactive for cofilin in cortex and
hippocampus of 4 month old Tg19959 mice but not wildtype
littermates (Fig. 2d). They are likely related to the pathologic
process in AD because they are found in the vicinity of plaques.
Cofilin mRNA levels are unchanged in APP transgenic
mouse model compared to wildtype
To investigate the mechanisms of increased cofilin protein
levels, we first examined transcription. We extracted total RNA
from brains of Tg19959 mice and wildtype littermates. Reverse
transcription followed by real time PCR showed no change in
cofilin mRNA levels in Tg19959 mice compared to wildtype
littermates (Fig. 3, three independent trials). Therefore, the
mechanism leading to increased cofilin protein levels occurs
post-transcriptionally.
MiR-103 and miR-107 repress cofilin translation
A translational regulatory mechanism of current interest
involves miRNAs. We hypothesized that miRNAs might be
responsible for control of cofilin translation. Sequence analysis
predicted that the 39UTR of cofilin mRNA is targeted by miR-103
and miR-107 (Fig. 4a, upper panel). To confirm a functional
interaction between miR-103 or miR-107 and the predicted target
region in the cofilin 39UTR, we constructed a miR luciferase
reporter, pMIR-luc-CmTR (Cofilin miRNA-103/107 Target
Region, Figure 4a, lower panel). We then co-transfected the
pMIR-luc-CmTR reporter construct with miR-103, miR-107, or
control oligos into HEK293 cells.
At 72 hours, the samples co-transfected with miR-103 or miR-
107 had a 33% decrease in luciferase activity compared to samples
co-transfected with control oligo (Fig. 4b). These results suggest
that miR-103 and miR-107 bind the putative target sequence in
the cofilin 39UTR and functionally repress translation of the
upstream gene. As a negative control, the target region putatively
binding miR-107 was mutated, and co-transfection with miR-107
no longer repressed luciferase expression (Fig. 4b).
The luciferase experiment used only a fragment of the cofilin
39UTR, and it is possible that inclusion of the entire 39UTR might
have different results. Thus, as further evidence of a functional
interaction between miR-107 and endogenous cofilin mRNA, we
determined whether silencing miR-107 would elevate cofilin
protein levels. Since mature miR-103 and miR-107 share the
same seed region and are otherwise identical except for one
nucleotide (Fig. 4a), and since both identically repress expression
of the luciferase reporter construct (Fig. 4b), we only tested miR-
107. We transfected anti-miR-107 inhibitor or control oligo into
Swe-N2a cells. After 72 hours, the cells in which miR-107 was
down-regulated had higher cofilin protein levels compared to
controls (Fig. 4c).
Mature miR-103 and miR-107 levels are decreased while
cofilin levels are elevated in APP transgenic mouse brains
We next examined mature miR-103 and miR-107 levels in 4-
month-old Tg19959 mouse brains by reverse transcription
followed by Taqman real time PCR. Brain levels of mature
miR-107 were decreased by 28% and miR-103 by 22% in
Tg19959 mice compared to wildtype littermates (Fig. 5).
Figure 1. Cofilin protein level is elevated in APP transgenic mouse brain and primary neurons. (a) Western blots of brain lysates show
elevated cofilin protein levels in 4-month-old Tg19959 mice compared to wildtype littermates. The graph plots the cofilin/tubulin ratios for the blots
shown, together with data from an independent replicate (total n=10 Tg, n=9 Wt). Mean 6 SEM is shown to the right of each group of raw data
points. P=0.0084 (two tailed t-test) comparing Tg (n=10) vs Wt (n=9). (b) Western blots of cell lysates show elevated cofilin protein levels in
Tg19959 primary neurons (DIV 16) (n=7 embryos) compared to wildtype littermate neurons (n=4 embryos). The graph plots the cofilin/tubulin ratios
for the blots shown. Mean 6 SEM is shown to the right of each group of raw data points. P=0.0012 (two tailed t-test) comparing Tg (n=7) vs Wt
(n=4).
doi:10.1371/journal.pone.0015546.g001
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protein levels were measured and found to be elevated in Tg19959
mice (Fig. 1a).
Overexpression of active cofilin is sufficient to induce
formation of cofilin rods in primary neurons
Cofilin protein can be activated through dephosphorylation at
residue Ser3 by upstream phosphatases. To determine whether
increased expression of active cofilin is sufficient to induce
formation of rod-like structures, we transfected DIV6 primary
neurons from wildtype mouse embryos with a constitutively active
cofilin-GFP construct (cofilin-S3A-GFP). Twenty-four hours after
transfection, we observed formation of rod-like structures (Fig. 6,
upper panel). As a control, no rod-like structures were observed
after transfection with an inactive cofilin-GFP construct (cofilin-
S3E-GFP) (Fig. 6, lower panel).
Discussion
Aggregates of cofilin and actin occur in human AD brains [1,2],
but are less well appreciated than amyloid plaques or neurofibril-
lary tangles. Rod-like structures containing cofilin and actin also
form in cell [3] and animal [9,18] models of AD. Several lines of
evidence suggest that such cofilin-actin rods are pathophysiologi-
cally important. First, they form under pathologic conditions, such
as energy depletion, excitotoxicity, oxidative stress, and Ab
exposure [3,7,8]. Second, they have functional consequences.
Feaney and colleagues showed that neurodegeneration in
Drosophila and mouse models of tauopathy was associated with
formation of actin-rich rod-like structures, and neurodegeneration
could be markedly attenuated by genetic manipulations to reduce
actin accumulation [18]. Formation of cofilin-actin rods may also
be important in recruitment of phosphorylated tau into neuropil
threads [9].
Our study investigates the mechanisms underlying the forma-
tion of cofilin rods. We show that miR-103 and miR-107 bind to
the 39UTR of cofilin mRNA as predicted, and repress translation
of cofilin. Decreasing miR-107 elevates cofilin protein levels, and
overexpression of active cofilin induces formation of cofilin-actin
rods. Finally, we show in a transgenic APP mouse model that brain
levels of miR-103 and miR-107 are decreased, with corresponding
increases in brain cofilin protein levels, and formation of cofilin-
actin rods or aggregates in primary neurons and brain sections.
Since overexpression of inactive cofilin does not induce rod
formation, the increased cofilin protein levels seen with decreased
miR-103/107 in AD must be followed by activation of the cofilin,
in order to lead to rod formation. The regulation of cofilin activity
in AD is thus a key topic for future elucidation.
Of note, a recent report suggests that many mammalian
miRNAs may work primarily by decreasing levels of target
mRNAs ([19] and references therein). Whether this applies in
particular to miR-107 and miR-103 and their interaction with
cofilin mRNA remains to be elucidated. We did not observe any
difference between APP mice and wild type littermates in cofilin
mRNA levels, suggesting miR-103 or miR-107 may regulate
cofilin expression primarily by decreasing translational efficiency.
These are the first observations to indicate that miRNA involved
protein regulation may contribute to formation of abnormal cyto-
skeletal aggregates in AD pathogenesis. Of note, miR-107 levels are
also decreased in human AD brain, where it was associated with
increased expression of BACE1 [12]. This previous work connects
miRNA with amyloid accumulation. However, it is well-established
that a given miRNA may regulate multiple targets [20]. Our data su-
pportsanadditionalroleformiR-107inADpathogenesis,throughup-
regulation of cofilin and subsequent perturbation of the cytoskeleton.
Materials and Methods
Ethics Statement
All experiments were approved by the Institutional Animal Care
and Use Committee at Weill-Cornell Medical College. Protocol
number: 2010-0025.
Experimental animals
Tg19959 mice were obtained from Dr. George Carlson
(McLaughlin Research Institute, Great Falls, MT). Tg19959 mice
were constructed by injecting FVB6129S6 F1 embryos with a
cosmid insert containing human APP695 with two familial AD
mutations (KM670/671NL and V717F), under control of the
hamster PrP promoter [21].
Primary neuronal culture and N2a cell line
Primary neuronal cultures were derived from cerebral cortex
and hippocampus of embryonic day 18 Tg19959 or wild-type
littermate embryos, as described previously [22] with modifica-
tions. Cortices and hippocampi were incubated with 0.25% trypsin
and then triturated in glass pipettes. Dissociated neurons were
plated initially in 10% FBS/DMEM on poly-D-lysine-treated
(0.1 mg/ml; Sigma) coverslips or dishes. They were switched
Figure 2. Cofilin rods are increased in APP transgenic mouse neurons compared to wild type littermate neurons. (a) Rod-like
structures immunoreactive for cofilin (arrowheads) are detected in Tg19959 primary neurons (DIV 20) permeabilized with ice-cold methanol. Scale
bars represent 100 mm. (b) The fraction of neurons (DIV 20) containing such rod-like structures is 23.963.1% in Tg19959 neurons (n=200 neurons
from 3 embryos), but only 7.362.1% in wildtype littermate neurons (n=243 neurons from 3 embryos). **P=0.00027, two tailed t test. (c) Rod-like
structures immunoreactive for cofilin are detected in Tg19959 primary neurons permeabilized with Triton X-100. These structures are not stained by
rhodamine-phalloidin. (d) Cofilin aggregates (arrows) are detected in 4 month old Tg19959 mouse brains but not in wildtype littermates. Scale bar
represents 50 mm.
doi:10.1371/journal.pone.0015546.g002
Figure 3. Cofilin mRNA levels are unchanged in APP transgenic
mouse brains compared to wildtype brains. There is no change in
cofilin mRNA levels, normalized to levels of hypoxanthine phosphor-
ibosyl transferase (Hprt1) mRNA, in brains of Tg19959 mice (n=8)
compared to wildtype littermates (n=9).
doi:10.1371/journal.pone.0015546.g003
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supplement (Invitrogen, Gaithersburg, MD) and 2 mM L-
glutamine. For immunofluorescence, ,4610
5 neurons were
plated per well in six-well plates containing coverslips. For western
blot, ,3.3610
6 neurons were plated per 100-mm-diameter dish.
Genotyping was performed on cerebellum from the same embryo.
Mouse N2a neuroblastoma cells stably transfected with human
APP695 carrying the 670/671 Swedish mutation (Swe-N2a) were
grown as described previously [23].
Sample preparation from brains and cells
Mice were deeply anesthetized with intraperitoneal sodium
pentobarbital and transcardially perfused with ice-cold saline. The
brains were removed and dissected on ice. One hemisphere was
stored in RNA Later Solution (Ambion) for subsequent Trizol
RNA extraction (Invitrogen). The frontal third of the other
hemisphere was homogenized in RIPA buffer for western blot
analysis. Primary neurons and N2a cells were homogenized and
prepared in Trizol for RNA extraction and in RIPA buffer for
Figure 4. MiR-103 and miR-107 repress cofilin translation. (a) Upper panel: MiR-103 and miR-107 are predicted to bind the 39UTR of cofilin
mRNA. Mature miR-103 and miR-107 differ only at the boxed position. The seed region predicted to bind the cofilin 39UTR is shaded in gray. Lower
panel, pMIR-luc-CmTR construct: A portion of the Cofilin 39UTR containing the putative miR-103/107 Target Region (italicized) was inserted
downstream of a luciferase reporter. The inserted CFL1 sequence is numbered 319–362 according to NCBI accession NM_005507. As a negative
control, the putative miRNA binding site was mutated (red) to examine the specificity of interaction with miR-107. (b) MiR-103 and miR-107 repress
expression of luciferase from the pMIR-luc-CmTR reporter construct in HEK293 cells. MiR-107 vs control, *P=0.027; miR-103 vs control, *P=0.028;
n=3 wells per miR, ANOVA with post-hoc Scheffe ´ testing. Experiments were replicated 3 times. As a negative control, expression of luciferase from
the construct with mutated binding region was no longer suppressed by miR-107. (c) Silencing of miR-107 elevates cofilin protein levels in Swe-N2a
cells. n=3 plates per condition, *P=0.034, Student’s t-test.
doi:10.1371/journal.pone.0015546.g004
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BCA protein assay (Thermo Scientific).
Western blot analysis
Samples with equal protein amounts were separated by Tricine-
SDS gel electrophoresis and transferred to PVDF membrane using
the iBlot dry blotting system (Invitrogen). Membranes were
blocked with 5% milk/0.1% Tween20 in TBS for 1 hour at
room temperature, followed by incubation with primary antibod-
ies overnight at 4uC. Signal was detected using HRP-conjugated
secondary antibodies and enhanced chemiluminescence (Thermo
Scientific). Blots were scanned at 300 dpi and densitometry was
performed using ImageJ 1.42q (NIH). Antibodies were mouse
monoclonal anti-tubulin (Sigma, 1:10000), rabbit polyclonal anti-
cofilin (Cytoskeleton Inc., 1:500), HRP-conjugated goat anti-
mouse IgG (1:2000) and goat anti-rabbit IgG (1:3000) (KPL).
Fluorescence immunostaining, microscopy, and
quantification
Primary neurons were fixed with 4% paraformaldehyde + 0.1%
glutaraldehyde + 1% sucrose in PBS and permeabilized with ice
cold methanol at 220uC for 3 minutes. They were blocked with
2% normal goat serum + 2% BSA in TBS [3], followed by
incubation with anti-cofilin antibody (rabbit polyclonal, Cytoskel-
eton Inc., 1:500), anti-actin antibody (mouse clone AC-40, Sigma,
1:100), and then Alexa 488-conjugated donkey anti-rabbit IgG
and Alexa 546-conjugated goat anti-mouse IgG (Invitrogen). For
rhodamine-phalloidin staining, cells were permeabilized with
Triton X-100 at room temperature for 10 minutes instead of
ice-cold methanol [3]. Brain slices were fixed in 4% paraformal-
dehye and permeabilized with ice cold methanol at 220uC for 5
minutes and then processed as above for cofilin.
Immunofluorescence was examined by confocal microscopy
using an Axiovert 100M inverted microscope equipped with an
LSM 510 laser scanning unit and a 6361.4 NA plan apochromat
objective (Zeiss), Ar488, HeNe1543 nm lasers, and LP560 and
BP505–530. Optical sections were no thicker than 0.8 mm. Pseudo
color was added to images from different channels using Adobe
Photoshop. Cofilin rods were identified as thread-like structures
Figure 5. MiR-103 and miR-107 levels are decreased in APP
transgenic mouse brains. (a) Levels of mature miR-107 are
significantly decreased in brains of 4 month-old Tg19959 mice
compared to wild-type littermates. N=5 brains/genotype, each brain
in triplicate, *P=0.04, Student’s t-test. Cofilin protein levels in these
same brains are increased (Figure 1a). (b) Levels of mature miR-103 are
significantly decreased in brains of 4 month-old Tg19959 mice
compared to wild-type littermates. N=5 brains/genotype, each brain
in triplicate, *P=0.04, Student’s t-test. Cofilin protein levels in these
same brains are increased (Figure 1a).
doi:10.1371/journal.pone.0015546.g005
Figure 6. Overexpression of active cofilin (cofilin-S3A, top
panel) induced formation of rod-like structures (arrows) in
wild-type neurons. The inactive form (cofilin-S3E, bottom panel) did
not. Images are merged GFP fluorescence and phase contrast. Scale bar
represents 100 mm.
doi:10.1371/journal.pone.0015546.g006
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compare the frequency of rods in primary neurons from transgenic
mice and wild-type littermates, at least two hundred neurons were
examined for each genotype, and the fraction of neurons with rods
was quantified, as previously described [3].
RT-PCR of cofilin mRNA
Total RNA was extracted from fresh 4-month-old mouse brains
using Trizol (Invitrogen) standard extraction. cDNA synthesis and
PCR analysis were performed using the cDNA reverse transcrip-
tion kit (Invitrogen) and SYBR Green PCR Master Mix (Applied
Biosystems). Hprt1 was utilized as internal control. In preliminary
studies, amplification curves for Hprt1, normalized to the same
amount of RNA template, were identical between Tg19959 and
wildtype littermate mice. Hprt1 has also previously been used as a
housekeeping control in AD [24].
Bioinformatic Predictions
The cofilin 1 (CFL1, non-muscle) mRNA sequence (NCBI
accession NM_005507) was obtained from NCBI. Potential
binding between cofilin mRNA and miRNAs was analyzed using
the online resources at microrna.org, pictar.org, targetscan.org,
microrna.sanger.ac.uk, and sfold.wadsworth.org. MiR-103/107
binding to CFL1 is listed as ‘‘target sites of conserved microRNA
with good mirSVR scores’’ at microRNA.org.
Plasmids
pMIR-luc-CmTR. A 44-bp fragment of the Cofilin 39UTR
containing the potential miR-103/107 Target Region was
synthesized (Invitrogen) and inserted into the multiple cloning
sequence of pMIR-Report (Ambion), downstream of luciferase
(Fig. 4a, lower panel). As a negative control, a fragment in which
the putative miRNA binding site was mutated at all 7 residues was
inserted into the same pMIR-Report plasmid. The 7 mutated
nucleotides of the inserted CFL1 mRNA fragment were at
positions 334–340 (from the 59 end of NCBI accession
NM_005507), corresponding to positions 2–8 from the 59 end of
miR-107/103 (the ‘‘seed region’’). Cofilin-S3A-GFP and
cofilin-S3E-GFP plasmids were generous gifts from J.
Bamburg (Colorado State University, Fort Collins, CO). The
human cofilin S3A (constitutively active form) and S3E
(constitutively inactive form) were inserted into pEGFP-N1,
generating a fusion fluorescent protein to C-terminal of cofilin
S3A and S3E [3,7]. Cultured wildtype primary neurons at DIV6
were transfected using lipofectamine 2000 (Invitrogen), according
to the manufacturer’s instructions. Live images were captured
24 hours after transfection by fluorescence microscopy.
MicroRNA functional assay
HEK293 cells were transfected using lipofectamine 2000
(Invitrogen), according to the manufacturer’s instructions.
HEK293 cells are standardly used for luciferase assays and do
not express miR-103 or miR-107 [25,26]. Cells were co-
transfected with (1) pMIR-luc-CmTR or the negative control
construct with mutated binding region, (2) miR-103, miR-107, or
control oligos for miRNAs, and (3) a b-galactosidase control vector
provided for normalization of transfection efficiency (pMIR-
REPORT miRNA Expression Reporter Vector System, Ambion).
In preliminary studies, samples were analyzed at 24, 48, and
72 hours. The greatest changes occurred at 72 hours, which was
the time point subsequently used. Luciferase and b-galactosidase
activities were measured using the Dual-Light System (Applied
Biosystems) and an Optocomp I luminometer (MGM Instruments)
according to the manufacturers’ instructions. For each sample, the
luciferase reading was divided by the b-gal reading. All luciferase/
b-gal ratios were then divided by the average luciferase/b-gal ratio
of the control samples. These normalized ratios are plotted in
Fig. 4b.
MicroRNA silencing
Swe-N2a cells were transfected using lipofectamine 2000
(Invitrogen) with an anti-miR-107 silencing oligo or control oligo
(Ambion). Cofilin protein levels were analyzed after 72 hours by
western blot as described above.
Quantitation of endogenous mature miR-103 and
miR-107
Total RNA, including small RNAs, was extracted from fresh 4-
month-old mouse brains using the mirVana miRNA Isolation Kit
(Ambion). Mature miRNA levels were measured by sequence-
specific reverse transcription followed by real-time PCR using
Taqman probes for detection. Kits containing the RT primers,
PCR primers, and Taqman probes were obtained from Applied
Biosystems (Taqman microRNA assay kit 4427975, assay ID
000439 for miR-103, assay ID 000443 for miR-107). Let-7b was
used as housekeeping internal control (assay ID 000378). There
was no statistically significant difference between let-7b levels in
human AD and control brains [13].
For each sample, the cycle number Ct to reach threshold
fluorescence was determined in triplicate for each miRNA and let-
7b. DCt (miRx) = Ct (miRx) – Ct (let-7b) was calculated, and
Student’s t-test was performed to compare DCt (miRx) in Tg19959
mice vs wildtype littermates. To determine relative amounts of
miRx in Tg19959 mice vs wildtype mice, data are presented using
the 2
2DDCt method. For each sample and miRNA, 2
2DCt was
calculated, and these values were divided by the average 2
2DCt in
wildtype brains. Figure 5 shows 2
2DCt (Tg or wt)/average (2
2DCt (wt)).
Statistics. Unpaired comparisons between two groups were
performed using Student’s t-test assuming equal or unequal
variances as determined by F-test. Comparisons involving more
than two groups were performed using analysis of variance with
post-hoc Scheffe testing to adjust for multiple comparisons. The
alpha level for all tests was set at 0.05. Calculations were
performed using Excel 2003 (Microsoft), Prism 5.01 (Graphpad),
or Statview 5.0.1 (SAS Institute). In all figures, bar graphs show
mean 6 standard error of the mean.
Supporting Information
Figure S1 Cofilin rods (top panel) in Tg19959 primary
neurons are also recognized by an antibody to total actin
(bottom panel). Neurons were permeabilized with ice cold
methanol. Arrows indicate cofilin rods overlapping with actin
staining. Scale bar represents 100 mm.
(TIF)
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